Keystone Symposia

Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.

E. Dale Abel, M.D., Ph.D.#
William S. Adams Professor of Medicine
Chair and Executive Medical Director
Department of Medicine
David Geffen School of Medicine and UCLA Health

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Karen Adelman, Ph.D.
Biological Chemistry and Molecular Pharmacology
Harvard Medical School

Zoltan Arany, M.D., Ph.D.
University of Pennsylvania

Eric H. Baehrecke, Ph.D.
Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
NIAID, National Institutes of Health

Morris J. Birnbaum, M.D., Ph.D.#
Retired CSO
Pfizer, Inc.

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Esther Breij, Ph.D.
Vice President, Head of Translational Research

Cherié Butts, Ph.D.#
Medical Director
Digital & Quantitative Medicine
Biogen, Inc.

Jonathan D. Chesnut, Ph.D.
Senior Director, Cell Biology R&D
Life Sciences Solutions Group
Thermo Fisher Scientific

Ian M. Colrain, Ph.D.#
President and CEO

Roger D. Cone, Ph.D.
Life Sciences Institute
University of Michigan

Feng Cong, Ph.D.
Chemical Biology & Therapeutics
Novartis Institutes for BioMedical Research

Thomas Conlon, Ph.D.
Chief Scientific Officer
Michelson Philanthropies,
Michelson Found Animals Foundation, Inc., &
Michelson Medical Research Foundation

Kizzmekia S. Corbett-Helaire, Ph.D.
Assistant Professor of Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health

Carolyn B. Coyne, Ph.D.
Molecular Genetics and Biology
Duke University

Ana Maria Cuervo, M.D., Ph.D.
Professor, Department of Developmental and Molecular Biology
Co-Director, Institute for Aging Studies
Albert Einstein College of Medicine

Chi Van Dang, M.D., Ph.D.#
Ludwig Institute for Cancer Research
Department of Oncology
Johns Hopkins University
School of Medicine

Robertus de Bruin, Ph.D.
Vice Dean (EDI), Faculty of Life Sciences
Professor of Molecular Cancer Biology
Laboratory for Molecular Cell Biology
University College London

Weiwen Deng, Ph.D.
Principal Scientist
Amgen, Inc.

Edward A. Dennis, Ph.D.#
Chancellor Distinguished Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Suzanne Devkota, Ph.D.
Associate Professor
Karsh Division of Gastroenterology
Cedars-Sinai Medical Center

Anwesha Dey, Ph.D.
Discovery Oncology
Genentech, Inc.

Richard D. DiMarchi, Ph.D.#
Distinguished Professor
Indiana University

Jessica L. Dunne, Ph.D.
Scientific Director, T1D
Novo Nordisk

Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.

Sandra J. Engle, Ph.D.
Senior Director
Translational Biology
Biogen, Inc.

Stacey D. Finley, Ph.D.
Gordon S. Marshall Early Career Chair and Associate Professor
University of Southern California

Patrick Finn, Ph.D.
Senior Director
Rare Diseases

Kelly A. Frazer, Ph.D.
Director, Institute for Genomic Medicine
Professor of Pediatrics
Division Chief, Genome Information Sciences
University of California San Diego School of Medicine

Maria C. Freire, Ph.D.#
The Freire Group

Mattias Fyrenius#
Publishing Director
Bonnier Carlsen

Dmitry I. Gabrilovich, M.D., Ph.D.
Chief Scientist
Cancer Immunology

Stephan Gasser, Ph.D.
Senior Principal Scientist
Roche Innovation Center Zurich

Jason E. Gestwicki, Ph.D.
University of California, San Francisco

Geoffrey S. Ginsburg, M.D., Ph.D.
Chief Medical and Scientific Officer
All of Us Research Program
Division of Medical and Scientific Research
National Institutes of Health

Margaret A. Goodell, Ph.D.#
Professor and Chair
Department of Molecular and Cellular Biology
Director of Stem Cells & Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Lora K. Heisler, Ph.D.
Chair in Human Nutrition
Obesity and Food Choice
Rowett Institute, University of Aberdeen

Michael J. Holtzman, M.D.
Selman and Herman Seldin Professor, Medicine
Director, Pulmonary and Critical Care Medicine
Professor, Cell Biology and Physiology
Washington University in St. Louis
President, NuPeak Therapeutics

Prisca Honore, Ph.D.
Executive Director
Immunology Discovery

Tony Hunter, Ph.D.#
Professor and Principal Investigator
Molecular Cellular Biology Laboratories
The Salk Institute for Biological Sciences

Stefan Irion, M.D.
Vice President CNS Research
BlueRock Therapeutics

Aron B. Jaffe, Ph.D.
Senior Vice President, Head of Research
Chroma Medicine

Deborah L. Johnson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia on Molecular and Cellular Biology

Véronique Kiermer, Ph.D.#
Chief Scientific Officer
Public Library of Science (PLOS)

Katherine W. Klinger, Ph.D.
Global Head
Translational Sciences

Jean K. Lim, Ph.D.
Associate Professor
Icahn School of Medicine at Mount Sinai

Patrick Mayes, Ph.D.
Executive Director
Immuno-Oncology Antibodies
Incyte Research Institute

Laura F. Michael, Ph.D.
Associate Vice President
Diabetes and Complications Therapeutic Area
Eli Lilly and Company

Valerie Mizrahi, Ph.D.
Institute of Infectious Disease and Molecular Medicine (IDM)
University of Cape Town

Walter H. Moos, Ph.D.#
Managing Director, Pandect Bioventures
Professor (adj), University of California, San Francisco
President (ret), SRI Biosciences, Stanford Research Institute
Chairman (emer), ShangPharma Innovation

Lily Y. Moy, Ph.D.
Director, Pharmacology
Quantitative Biosciences
Merck & Co.

Anne N. Murphy, Ph.D.
Vice President, Biology
Cytokinetics, Inc.

Shruti Naik, Ph.D.
Assistant Professor, Pathology
New York University Langone Health

Lee A. Niswander, Ph.D.
Professor and Chair
Molecular, Cellular and Developmental Biology
University of Colorado Boulder

Anne O'Garra, Ph.D., FRS, FMedSci#
Senior Group Leader
The Francis Crick Institute

Deborah Palliser, Ph.D.
Immunology Strategy Lead
Rare Diseases Drug Discovery Unit

Manu Omar Platt, Ph.D.
Director, Center for Biomedical Engineering Technology Acceleration
Senior Investigator, NIBIB
National Institutes of Health

Laszlo Radvanyi, Ph.D.
President and Scientific Director
Ontario Institute for Cancer Research

Richard M. Ransohoff, M.D.
Venture Partner
Third Rock Ventures

Rino Rappuoli, Ph.D.
Scientific Director
National Institute for Pandemic Preparedness (NIPP)
Fondazione Biotecnopolo di Siena

Wendy Kimryn Rathmell, M.D., Ph.D.#
Professor and Chair
Vanderbilt University Medical Center

Bing Ren, Ph.D.
Ludwig Institute for Cancer Research

Christopher J. Rhodes, BSc, PhD
Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca
Professor, University of Chicago

Ann-Marie T. Richard, Ph.D.
Director, Patient Engagement
Internal Medicine Research Unit

Frank Rigo, Ph.D.
Vice President
Functional Genomics and Drug Discovery
Ionis Pharmaceuticals

Mark Rolfe, Ph.D.
Senior Vice President
Oncogenesis Thematic Research Center
Bristol Myers Squibb

Pamela C. Ronald, Ph.D.
Distinguished Professor
Plant Pathology and the Genome Center
University of California, Davis

Carla V. Rothlin, Ph.D.
Yale University

Deepak Sampath, Ph.D.
Vice President, Head of Research

Terry Lee Sheppard, Ph.D.#
Chief Scientific Officer
Keystone Symposia on Molecular and Cellular Biology

Boris Striepen, Ph.D.
Professor of Microbiology and Immunology
Department of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

Lori Sussel, Ph.D.#
Professor and Director of Research
Basic and Translational Research Division, Barbara Davis Center
University of Colorado Anschutz Medical Campus

Paul K.H. Tam, ChM
Chair Professor & VP, Macau University of Science and Technology
Emeritus Professor, and Honorary Clinical Professor of Surgery, The University of Hong Kong

Cormac Taylor, Ph.D.
Professor, Cellular Physiology
University College Dublin

Cornelia Liu Trimble, M.D.
Gynecology and Obstetrics, Oncology, and Pathology
Johns Hopkins University School of Medicine

Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated

Elizabeth Villa, Ph.D.
Associate Professor
University of California, San Diego

Amy J. Wagers, Ph.D.
Stem Cell and Regenerative Biology
Harvard University

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Mary E. Wilson, M.D.
Internal Medicine and Microbiology & Immunology
University of Iowa and the Iowa City VA Medical Center

Joseph C. Wu, M.D., Ph.D.#
Stanford University

Juleen R. Zierath, Ph.D.#
Department of Molecular Medicine and Surgery
Karolinska Institutet

Arturo Zychlinsky, Ph.D.
Cellular Microbiology
Max Planck Institute for Infection Biology

plus representatives to be announced from:
Bill & Melinda Gates Foundation
BioLegend, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Cell Research
Cystic Fibrosis Foundation
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson
Sensei Biotherapeutics
TCR² Therapeutics